Joint inspections with eight other regulators carried at six of Ranbaxy‘s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
first published: May 9, 2016 03:18 pm
A collection of the most-viewed Moneycontrol videos.
The Lawyer Renting in a 120-year-old building in South Mumbai | The Tenant
Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
